Arcus Biosciences Announces New Employment Inducement Grants
Arcus Biosciences granted 2 new employees options to purchase 9,150 shares at $23.83 and RSUs covering 4,600 shares as employment inducement awards. The grants were made under the company's 2020 Inducement Plan pursuant to the NYSE inducement exception and priced at the October 8, 2026 closing price.
Key figures
- Rsu shares
- 4600
- Option shares
- 9150
- Exercise price
- 23.83
- Employees granted
- 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.